HomeMy WebLinkAboutContract 54820 DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-B895D117DF60
CSC No.54820
INTERLOCAL AGREEMENT BETWEEN THE CITY OF FORT WORTH
AND UT SOUTHWESTERN MEDICAL CENTER FOR THE ❑FW COVID-19 COMMUNITY
PREVALENCESTUDY
This Interlocal Agreement("Agreement")is between City of Fort Worth("CITY"),a Texas home rule
municipality and the UT Southwestern Medical Center("UT SOUTHWESTERN")and shall be effective
on the date that the signature of the last party is affixed ("Effective Date"). The CITY and UT
SOUTHWESTERN have reviewed this Agreement and each make the following findings:
WHEREAS, COVID-19 may present symptoms including fever, cough, and shortness of breath
and with outcomes ranging from mild to severe illness and, in some cases,death; and
WHEREAS,on March 11,2020,the World Health Organization declared COVID-19 a worldwide
pandemic;and
WHEREAS,President Donald Trump,Governor Greg Abbott, and Tarrant County Judge B. Glen
Whitley, and Mayor Betsy Price have issued Declarations of Disaster for the United States, the State of
Texas,Tarrant County,and the CITY,respectively;and
WHEREAS,on March 27,2020,President Donald Trump signed the Coronavirus Aid Relief and
Economic Security Act ("CARES Act") providing financial aid to those impacted by the COVID-19
pandemic, including local governments; and
WHEREAS,the CITY has received CARES Act Coronavirus Relief Funds("FUNDS"),awarded
as C.F.D.A. #21.019 to reduce the impact of necessary expenditures incurred due to the public health
emergency with respect to COVID-19; and
WHEREAS, the U.S. Treasury has issued guidance on CARES Act State and Local
Government Aid FUNDS on April 22,2020,May 4, 2020,May 28,2020, and June 24, 2020,and will
continue to issue guidance and clarification on the appropriate use of these FUNDS; and
WHEREAS,U.S.Treasury guidance states that COVID-19 related expenses for public safety
measures undertaken in response to COVID-19 is an eligible use of FUNDS; and
WHEREAS, U.S. Treasury guidance states that costs of providing COVID-19 testing,
including scrological testing and contact tracing is an eligible use of FUNDS; and
WHEREAS, U.S. Treasury guidance states that payroll expenses for public safety, public
health,health care,human services,and similar employees whose services are substantially dedicated
to mitigating the COVID-19 health emergency is an eligible use of FUNDS; and
WHEREAS,on of June 12,2020,there had been more than 80,000 confirmed COVID-19 cases in
Texas and almost 20,000 COVID-19 cases in Dallas and Tarrant Counties; and
WHEREAS, UT SOUTHWESTERN and Texas Health Resources are joining forces to launch a
large COVID-19 prevalence study, the DFW COVID-19 Community Prevalence Study (the "STUDY"),
that encompasses Tarrant and Dallas Counties,the proposal for which is outlined in Exhibit"A";and
WHEREAS, other stakeholders are collaborating to fund the STUDY, the total cost of which is
valued at$8 million; and
OFFICIAL RECORD
I of 14 CITY SECRETARY
FT.WORTH, TX
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-B895D117DF60
WHEREAS, this Agreement is made pursuant to the authority of Sections 791.001-792.029 of
the Texas Government Code;and
WHEREAS,the expenses of any payments or performance required by this Agreement shall come
from current revenues legally available to the parties; and
WHEREAS,the subject of this contract is necessary for the benefit of the public and each party
has the legal authority to perform and provide the governmental function or service which is the subject
matter of this contract;
THEREFORE, for and in consideration of the mutual undertaking hereinafter set forth and for
adequate consideration given,the CITY and UT SOUTHWESTERN agree to the following:
1.
DISTRIBUTION OF FUNDS
The CITY shall distribute ONE MILLION DOLLARS ($1,000,000), up front, of FUNDS (the
"DISTRIBUTED FUNDS") for the STUDY to UT SOUTHWESTERN, which shall be used only for the
STUDY. DISTRIBUTED FUNDS not used by December 30, 2020 shall be returned to the CITY within
ten(10)business days thereafter.
UT SOUTHWESTERN shall use the DISTRIBUTED FUNDS to pay for, either in part or in full, the
expenses as specified in the Covid-19 Prevalence Study Distributed Funds Budget (the "BUDGET") as
provided in Exhibit "B". DISTRIBUTED FUNDS not used to pay for the expenses as specified in the
BUDGET are subject to recapture by the CITY.
UT SOUTHWESTERN acknowledges that,by receiving FUNDS as described herein,it is a Sub-Recipient
of the CITY's CARES Act FUNDS and shall follow guidelines as provided in Exhibit "C", 2 CFR Part
200, and all guidance issued by the U.S.Treasury pertaining to the proper use of FUNDS. ❑ISTRIBUTED
FUNDS not used in compliance with the CARES Act are subject to recapture by the CITY.
H.
REPORTING REQUIREMENTS
UT SOUTHWESTERN shall provide a detailed monthly statement describing how the DISTRIBUTED
FUNDS were utilized for the prior month. The monthly statements shall be due to the CITY on the fifteenth
(15th) day of each month. UT SOUTHWESTERN shall also comply with additional reporting
requirements, as requested by the CITY and mutually agreed in writing by UT SOUTHWESTERN,
throughout the duration of this Agreement.
III.
DOCUMENTATION AND AUDIT
UT SOUTHWESTERN shall keep and maintain all records relating to the DISTRIBUTED FUNDS for a
period of no less than five (5) years. UT SOUTHWESTERN agrees that CITY shall, upon reasonable
advance written notice, until the expiration of three (3) years after termination or expiration of this
Agreement, have access to and the right to examine any directly pertinent books, documents, papers and
records of UT SOUTHWESTERN involving monetary transactions between the Parties directly relating to
the Agreement and only as necessary to verify compliance with this Agreement. All costs of any such audit
shall be borne solely by CITY.
2of14
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-B895D117DF60
IV.
TERMITERMINATION
This Agreement shall become effective as of the Effective Date and shall continue in full force and effect
for an initial term ending December 30, 2020. Either CITY or UT SOUTHWESTERN may terminate this
Agreement upon seven (7)days' prior written notice to the other party. Upon termination or expiration of
this Agreement, UT SOUTHWESTERN shall return all unused DISTRIBUTED FUNDS to the CITY
within ten(10)business days thereafter.
V.
NOTICE
Any notice required or permitted to be delivered hereunder shall be deemed to have been given when
personally delivered, or if mailed, seventy-two (72) hours after deposit of the same in the United States
Mail,postage prepaid,certified,or registered,return receipt requested,properly addressed to the applicable
party hereto at its address set forth below:
UT SOUTHWESTERN: UT SOUTHWESTERN Medical Center
5323 Harry Hines Blvd
Dallas,TX 75390
Attn:Arnim Dontes, EVP of Business Affairs
CITY: City of Fort Worth
Attn:Jesus J. Chapa,Assistant City Manager
200 Texas Street
Fort Worth,TX 76 1 02-63 1 4
With copy to Fort Worth City Attorney's Office at same address
Such address may be changed from time to time by a party by providing written notice to the other in the
manner set forth above.
VI.
SEVERABILITY
If any provision of this Agreement shall be held to be invalid or unenforceable for any reason,the remaining
provisions shall continue to be valid and enforceable. If a court finds that any provision of this Agreement
is invalid or unenforceable,but that by limiting such provision it would become valid and enforceable,then
such provision shall be deemed to be written,construed,and enforced as so limited.
VII.
APPLICABLE LAW
Venue for any legal proceeding arising out of this Agreement shall be in a court of competent jurisdiction
in Tarrant County,Texas. This Agreement shall be governed by the laws of the State of Texas. Governing
law and venue shall survive termination of this Agreement.
VIII.
IMMUNITY
3 of 14
DocuSign Envelope ID:A89BD14C-CD99-4266-AEE0-6895D117DF60
It is expressly understood and agreed that in the execution of this Agreement, neither Party waives, nor
shall be deemed hereby to waive, any immunity or defense that would otherwise be available to it against
claims arising in the exercise of governmental powers and functions
IX.
ELECTRONIC SIGNATURES
Each Party agrees that:(1)any electronic signature(if any),whether digital or encrypted,to this Agreement
made by any Party is intended to authenticate this Agreement and shall have the same force and effect as
an original manual signature;and (ii)any signature to this Agreement by any Party transmitted by facsimile
or by electronic mail shall be valid and effective to bind that Parry so signing with the same force and effect
as an original manual signature. Delivery of a copy of this Agreement or any other document contemplated
hereby bearing an original or electronic signature by facsimile transmission (whether directly from one
facsimile device to another by means of a dial-up connection or whether mediated by the worldwide web),
by electronic mail in portable document format (.pdf) form, or by any other electronic means intended to
preserve the original graphic and pictorial appearance of a document,will have the same effect as physical
delivery of the paper document bearing an original or electronic signature. This Agreement may be
executed in multiple duplicate originals and all such duplicate originals shall be deemed to constitute one
and the same instrument. This Agreement may be executed in counterparts, each of which shall be deemed
to be an original, but all of which, taken together, shall be deemed to constitute a single instrument. The
Parties warrant and represent that a true and correct copy of the original of this Agreement shall be
admissible in a court of law in lieu of the original Agreement for all purposes of enforcement hereof
X_
LIABILITY
Fach Party shall be solely responsible for its own actions or inaction and the actions or failure to act of its
respective employees, agents, officers,officials, and contractors. Neither Party shall be responsible for the
actions, errors, omissions, negligence, misfeasance, or malfeasance of the other Party or any employee,
agent, officer,official or contractor of the other Party.
XI.
ENTIRE AGREEMENT
This Agreement represents the entire understanding between the parties with respect to its subject matter
and supersedes all prior representations.
EXECUTED by the duly authorized parties below:
UT SOUTHWESTERN MEDICAL CENTER
Doc-uS_igned by'
_
y= n
CFCe838�56834FO
Name: Megan G. Marks, Ph.D. Date 11/04/2020
Title: AVP Sponsored Programs Administration
Citv of Fort Worth Contract Compliance Manager
OFFICIAL RECORD
4 of 14
CITY SECRETARY
FT.WORTH, TX
DocuSign Envelope ID:A89BD14C-CD99-42BB-AEE0-B895D117DF60
By signing I acknowledge that I am the person
TBSUS Chaga responsible for the monitoring and
By: Jesus Chaps(Nov fO,202010:15 CST) administration of this contract, including
Name: Jesus J. Chapa ensuring all performance and reporting
Title: Assistant City Manager requirements.
Date: Nov 10, 2020
�7��i�r CoX
Approval Recommended: By: Justin Cox(Nov 4,202015:57 CST)
Name: Justin Cox
_&PA&0avp gmam—r- Title: Grants Manager
By: Brandon Bennett(Nov 10,2020 09:42 CST)
Name: Brandon Bennett Approved as to Form and Legality:
Title: Code Compliance Director
Attest:
By:
Name: Taylor Paris
hor p, �� Title: Assistant City Attorney
By: or Ronald P.Gonzales(Nov 1,202013:55 CST)
Name: Mary J. Kayser a44�aanIl� Contract Authorization:
1*FORT as
Title: City Secretary oo °°load VI&C 20-0516
Ado o��d Ordinance No. 24161-04-2020
Pva o=d
Od'�° �`�
nc onop5bgp
OFFICIAL RECORD
CITY SECRETARY
5of14 FT.WORTH, TX
DocuSign Envelope ID:A89BD 1 4C-CD99-428B-AEE0-B895D 1 17DF60
EXHIBIT A
DFW COVID-19 Community Prevalence Study
Proposal—June 12,2020
UTSouthwestern r,'% Texas Health
Medical Center � Resources'
DFW COVID-19 COMMUNITY
PREVALENCE STUDY
Study Proposal
June 12, 2020
6of14
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-BS95D117DF60
THE REAL PREVALENCE OF THE VIRUS
COVID-19 has infected morethan 2 million people in the United States and morethan 7.5 million people
worldwide.As of June 12,2020,there have been more than 80,000 confirmed cases in Texas and almost
20,000 cases in Dallas and Tarrant Counties. Despite the high number of confirmed cases, the true
prevalence of COVID-19 infections is believed to be underestimated, but to an unknown degree.There
are many reasons for this,including insufficient testing capacity early in the pandemic that led to under-
recognition of COVID-19 infections,as well as the fact that the CDC currently estimates that 35 percent of
those infected with COVID-19 are asymptomatic.
As a result, there are few studies quantifying community-level exposure in the United States.
Understanding the true prevalence of COVID-19 infection and the risk of exposure among vulnerable(e.g.,
racial ethnic minorities,low socioeconomic status)and high-risk(e.g.,health care workers,grocery store
workers) populations is critical to inform policy decisions regarding testing, re-opening businesses,
building infrastructure,and distributing resources for potential outbreaks in the future.
Exposure to COVID-19 and risk of infection may depend on several individual and community-level factors.
For exampie, nationwide, non-Hispanic blacks account for approximately one-third of COVI D-19-rel ated
hospitalizations despite only accounting for 13 percent of the population,Non-Hispanic whites account
for 60 percent of the nationwide population, but only 45 percent of those hospitalized. The factors
contributing to this disparity are likely multifactorial and may stem from differences in com orb idity(e.g.,
pulmonary disease, metabolic syndrome, and cancer predispose to worse outcomes), socioeconomic
status,and ability to social distance(e.g.,population density,housing).
While we have not yet seen evidence of similar disparities in Tarrant and Dallas Counties, we must
carefully monitor for COVID-19 hot spots created by racial/ethnic and socioeconomic residential
segregation,which would demand expanded interventions to mitigate COVID-19 spread and morbidity.
Additionally, a higher proportion of COVID-19 cases have occurred among persons with certain
occupations,including healthcare workers,fast responders,and day care and grocery store employees,
and those who have not been able to engage in social distancing.
It is currently unknown how long COVID-19-specific antibodies remain in the body after infection and to
what degree those antibodies confer Iong-term immunity.It is also unclear to what extent reinfection is
possible.Some patients in South Korea and China tested negative after recovering,only to test positive
again several weeks later.While recent reports indicate that these newly positive tests may represent
"biological residue" rather than new active infections,recovered patients must be followed for a much
longer period to truly understand reinfection risk. Such longitudinal studies are necessary to help us
estimate how long immunity might last by measuring changes in blood antibody and virus levels overtime.
This information is central to making educated policy decisions over the long term based on our
understanding of how herd immunity may develop in the population.
OUR SOLUTION
UT Southwestern and Texas Health Resources are joining farces to launch a large COVID-19 prevalence
study in early July that encompasses Tarrant and Dallas Counties.We will test 44,000 individuals,including
2
7 of 14
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-BS95D117DF60
14,000 high-risk workers and 30,000 community members—spanning the full breadth of socio-economic,
racial, and geographic diversity throughout Tarrant and Dallas Counties—to understand the true
prevalence of COVID-191n DfW.To address these short-term and longer-term needs,we propose a multi-
phase project.
Phase 1A
Phase 1A is proposed as a cross-sectional study to characterize the prevalence of COVID-19 exposure
and predisposing risk factors in Dallas and Tarrant Counties. We will include approximately 30,000
subjects for initial data collection.
Sampling strategy: We will take random samples from participants of different racial/ethnic,
socioeconomic,and population compositions(max 1 person per household).This strategy will efficiently
allow unto recruit equal numbers of patients across the three most common raciallethnic groups in Dallas
and Tarrant Counties(non-Hispanic white, non-Hispanic black,and Hispanic) and across socioeconomic
status—representing the diversity of the area and spectrum of COVID-19 related risks.
Patients who are selected will be mailed an initial invitation letter describing the study,followed by a
phone call to discuss the study with the selected household member,obtain informed consent,complete
required survey questions,and schedule a visit to the testing site.
Data and sample collection: Information collected over the phone from patients who are selected will
include demographics (age, sex, race/ethnicity), socioeconomic status,occupational status, household
composition, underlying health conditions, any contact with suspected or known COVID-19-positive
patients,potential COVI❑-19 symptoms,and self-reported social distancing. Patients will then travel to
the nearest of our testing sites,which will be increased and strategically placed throughout Tarrant and
Dallas Counties,to be tested for active and previous COVID-19 infections using PCR and antibody tests,
respectively.All patients will be notified of their results,and public health authorities will be notified of
positive results in order to follow-up with any necessary contact tracing.
Phase 113
Phase 113 will be a cross-sectional study to characterize the prevalence of COVID-19 exposure among
higher-risk groups who may serve as sources of disease spread. Higher-risk groups will be defined by
occupation, including restaurant and grocery store workers, childcare providers, meat-packing
employees, and those in the airline industry. Healthcare workers and first responders are not included
because we are conducting a separate prevalence study for those groups, funded by Lyda Hill
Philanthropies.We will include approximately 14,000 subjects from the various industries mentioned for
data collection.
Strategy: Because these higher-risk groups may be under-represented in population-based sampling
(Phase IA), we will partner with community organizations to facilitate random sampling of these
individuals and then proceed as in Phase IA.To make it easier for people to participate,on-site testing
can be arranged with employers.
3
8of14
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-BS95D117DF60
Phase 2
Beyond cross-sectional studies,longitudinal studies will help us understand immunity to COVID-19 after
infection and the potential for reinfection,as well as monitorthe development of new hot spots.As social
distancing policies relax,such monitoring will be key to curbing future outbreaks.
Phase 2 will be a longitudinal study to estimate changes in the presence of antibodies and virus in blood
tests aver time.We will monitor for new hot spots by assessingthe incidence of new COVID-19 exposures
among patients who initially tested negative by both antibody and PCR.In order to better understand the
development and duration of immunity to COVID-19,we will reassess antibody levels and look for new
active infections by PCR among those who initially tested antibody-positive.
Sampling strategy: From phases 1A and 16, a random sample of antibody-negative patients will be
selected for repeat PCR and antibody tests,along with all antibody-positive patients.
Data and sample collection:At six months and one year after the initial test, PCR and antibody tests will
be performed again.Patients also will be asked to report any influenza-like-illness symptoms in the past
three months,new medical conditions,change in occupational status,and self-reported social distancing
behavior.
COMMUNITY ENGAGEMENT AND REPORTING
To ensure success and educate the community,an engagement campaign will be launched along with the
study.Outreach tactics will include a dedicated website,fliers, media placements,and engagement with
places of worship in the community to encourage participation. Our current timeline is based on an
assumption of 45 percent participation by those who are contacted.The higher our participation rate,the
more quickly the study can be completed.
As the data will be analyzed by an internal team of data scientists at UT Southwestern,we will have the
ability to provide frequent updates to community stakeholders and government officials to help lead the
community through this challenging time.
MAKING IT HAPPEN
Philanthropy will be critical to helping UT Southwestern and Texas Health Resources identify the true spread
of COVID-19 in our community.The sooner we can secure funding and start this important work,the sooner
we can help business leaders and government officials make the best decisions in keeping North Texans safe
and the economy open.We hope that you will join us in supporting this critical endeavor.
4
9 of 14
maaREme9ec:A8g8w4CCD99-42BB-AEEO-BS95D1 17DR0
�
k
k �
� d
. o
2 $
§ a
§ � � �
k /
z !
- 2 2
� k \
§ I
2 \ E
� ® 5
/
$ § $
a � �
2 s
\ t
) \
E
£ E
k 2 $ S
! f a
/§ / , §)
® k \ q } } of
k a m E / « k % } j 2 \ \
E § � § ° � / 2 § ° / »
k k / « k
) \ j f \ k ) /
LLJ / \ E » E E k / E E \ E
> 2 18 ƒ ! * $ ) $ ] £ IR q a » * »
LU 2 z 2 /� � �
�
10 of14
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-B895D117DF60
8gg8$88888888$ = 88 8$888$ 58�3�c88888888+�.
nzr
v n a�.v .ten .�.. .t IA ry q= Y%W•n ' n y
N N N N N N N N N
�88$s_assN aN _. BaR��s8a 8~ Nw�
8gg8s888888R$8� = a38 yy�� r8r�8888'c8c dg888$$8c888�g8�88K$�
■+ � �S N ���^$�� � �!.q P �a q T Y ti����o�4 n �rF N�.
y F s Y^ .� ..q.• wwll�p�p Yr�..`�
- N N
N H H N H K N N
F
m
r ; .
k # � to t,�ba$w 9s
~ $ a o F
22
o�
5
A
S
11 of 14
0 0 0 0 Q O O O rn CDo 0 0 0 00 m
Ln uLn a
o o v o ry omo v "n v c 0 � � m u Ln mi
o ,A m in o n ry ui � N o vi o -4 o � rwn
N ❑ il"F .4 M rV r-I tD f- N �D 00 G
}
u �
Om
� to ir. crF to ir. to to to �
0
Q N LO � o0 0 � Qo 0 Qo 0
CD
a CNO O Q O ry Ln oQ U-Cl" W �
N Q N- lD rA
0 16 DO 00' V
u N ry N
Vl V} V'} V'} V} ih V} V} V} V}
00 O O O O O O Li Liu7 Uf
i C) Q Q Q O Q Q N ry N N
T n C C C O C C
r-1
C
10
7
47 4 +�
r r r N U
,C C C C +0) N
C N
N
O O O O N
a z CQ 0 0 0 N
m
-Z y ry rNv N rrQ cc r m N 0 LO
a
^� a 0 as ao OD as N N C Q7
W aTi l7 U C7 L7 Q7 v 'n o 0
'j w Y a d0 ao 40 dA 0 V N E U
C C C C r,4
E vi
Oa N 1 li N N Y^ u
,+T+ H H H H �tw � a 2 aU+ ❑m
N
3 E v a v o ❑- o a _�
o ❑ o o m V s a uw❑ ❑ nnm ❑ n ❑
m
u Ln sA L c � ❑ U
o �
co }
LL o
o
Di
a �
Q0 r
m �
0
w
w . cu
im chi
Q a
ao m c CL
n Ln a cu ti
v x ao R' m
LU C y q C Q -4 N Y y N
Vp
mna CL W 3rvi d vv ¢' a a c CL �U $ a ° m
2m W m
R mu ❑
ZP
cc
Q
Q E Y V IVE Q- -0 m m Q Z
j ai O ++ Q
a a `m = w m o v; q a�i p v o y ZA -
u a L7 0- U d rV +�.. C U LL m H u La l7
a
n�
C
L]J
C
Q�
CI}
3
❑
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-B895D117DF60
EXHIBIT C
Sub-Recipient Guidance
STANDARDS FOR FINANCIAL MANAGEMENT
In accordance with 2 CFR 200 — Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for Federal Awards, Organization will develop, implement and maintain financial
management and control systems,which include at a minimum accurate payroll, accounting and financial
reporting records,cost source documentation, effective internal and budgetary controls, and determination
of reasonableness, allowability and allocability of costs, and timely and appropriate audits and resolution
findings.
Organization shall maintain an effective accounting system,which will:
• Identify and record valid transactions
• Record transactions to the proper accounting period in which transactions occurred
• Describe transactions in sufficient detail to permit proper classification
• Maintain records that permit the tracing of funds to a level of detail that establishes that the funds
have been used in compliance with contract requirements
• Adequately identify the source and application of funds of each grant contract
• Generate current and accurate financial reports in accordance with contract requirements
REPORTS,INSPECTIONS,AND MONITORING REVIEWS
Organization will submit fiscal, progress, programmatic, and other reports as requested by County in the
approved format.
Any authorized representatives of the local, state or federal government have the right, at all reasonable
times,to inspect or otherwise evaluate the work performed or being performed and the premises in which
it is being performed. Organization will participate in and provide reasonable access to facilities for
assisting said representatives. All inspections and evaluations will be performed in such a manner as will
not unduly delay the work.
PARTICIPANT RECORDS
Organization grants County,the Inspector General,the Comptroller General of the United States,or any of
their duly authorized representatives, the right of timely and unrestricted access to any books, documents,
papers, or other records of Organization pertinent to the Contract, in order to make audit, examinations,
excerpts, transcripts and copies of such documents. This right also includes timely and reasonable access
by County fiscal and program personnel for the purpose of reviewing, interviewing, evaluating and
monitoring related to such documents.
County retains the right of access to Organization's records or the right to obtain copies of said records for
audit, litigation,or other circumstances that may arise.
These documents will be maintained and retained by the Organization in accordance with state and federal
retention schedules. If any litigation, claim, or audit involving these records begins before the retention
period expires,the Organization will retain the records and documents in accordance with state and federal
retention schedule or until litigation,claims,or audit findings are resolved,whichever is later.
ALLOWABLE COSTS
County payment to Organization does not stop the County from determining that certain costs were
ineligible for reimbursement. If the County determines that a cost the County has paid for is ineligible for
reimbursement, the Organization will refund the ineligible amount to the County. Tarrant County will
13 of 14
DocuSign Envelope ID:A898D14C-CD99-42BB-AEEO-B895D117DF60
determine whether costs submitted by Organization arc allowable and eligible for reimbursement.If Tarrant
County has paid funds to Organization for unallowable or ineligible costs, Tarrant County will notify
Organization in writing, and Organization shall return the funds to Tarrant County within thirty (30)
calendar days of the date of this written notice. Tarrant County may withhold all or part of any payments
to Organization to offset reimbursement for any unallowable or ineligible expenditure that Organization
has not refunded to Tarrant County, or if financial status report(s) required are not submitted by the due
date(s).
SINGLE AUDIT
An audit must be completed if required by 2 CFR Part 200.500-520. If the guidance does not require a
single audit,the Organization will notify County in writing.
Independent Single or Program-Specific Audit.If Organization within Organization's fiscal year, expends
a total amount of at least SEVEN HUNDRED FIFTY THOUSAND DOLLARS($750,000)in federal funds
awarded, Organization shall have a single audit or program-specific audit in accordance with the 2 CFR
200.The$750,000 federal threshold amount includes federal funds passed through by way of other agency
awards.The audit must be conducted by an independent certified public accountant and in accordance with
2 CFR Part 200 and Government Auditing Standards.
14 of 14
11/11/2020 M&C Review
Official
CITY COUNCIL AGENDA FfRTVORTII
DATE: 8/4/2020 REFERENCE**M&C 20- LOG 36COVID-19 PREVALENCE STUDY
NO.: 0516 NAME: AGREEMENT WITH UT SOUTHWESTERN
CODE: C TYPE: CONSENT PUBLIC NO
HEARING:
SUBJECT. Authorize Agreement with University of Texas Southwestern and Texas Health Resources
to Assist with Funding a COVID-19 Prevalence Study in Tarrant County, in an Amount Not
to Exceed $1,000,000.00, to be Funded from Existing Coronavirus Aid, Relief, and
Economic Security Act, Title V Funding (ALL COUNCIL DISTRICTS)
RECOMMENDATION:
It is recommended that the City Council authorize an agreement with the University of Texas
Southwestern and Texas Health Resources to assist with funding a COVID-19 prevalence study in
Tarrant County, in an amount not to exceed $1,000,000.00, to be funded from existing Coronavirus
Aid, Relief, and Economic Security Act, Title V Funding.
DISCUSSION:
The University of Texas Southwestern (UTSW) and Texas Health Resources are joining forces to
launch a large coronavirus disease 2019 (COVID-19) prevalence study that encompasses Tarrant
and Dallas Counties. They will test 44,000 individuals, including 14,000 high-risk workers and 30,000
community members, spanning the full breadth of socio-economic, racial, and geographic diversity
throughout Tarrant and Dallas Counties, to understand the true prevalence of COVID-19 in the
Dallas/Fort Worth (DFW) area.
As the data is analyzed by a team of data scientists at UTSW, they will provide frequent updates to
community stakeholders and government officials to help lead the community through this challenging
time. This will be a multi-phase project with the goal of assisting business leaders and government
officials in making the best decisions to keep North Texans safe and the economy open.
The source of funding for the study will be the Coronavirus Aid, Relief, and Economic Security
(CARES)Act, Title V funding received from the U.S. Treasury. Based on current federal criteria, all
funds not used by December 30, 2020 must be returned to the City.
This study will be for ALL COUNCIL DISTRICTS.
FISCAL INFORMATION/CERTIFICATION:
The Director of Finance certifies that funds are available in the current operating budget, as
previously appropriated, in the Grants Operating Federal fund to support the approval of the above
recommendation and execution of the agreement. Prior to an expenditure being incurred, the Code
Compliance Department and the Fire Department have the responsibility to validate the availability of
funds. This is an advance award.
TO
Fund Department Account Project Program Activity Budget Reference# Amount
ID ID Year Chartfield 2
FROM
Fund Department Account Project Program Activity Budget Reference# Amount
ID ID Year (Chartfield 2) ,
Submitted for City Manager's Office by_ Valerie Washington (6199)
apps.cfwnet.org/council_packet/mc_review.asp?I D=28085&counciidate=8/4/2020 1/2
11/11/2020 M&C Review
Originating Department Head: Jim Davis (6801)
Additional Information Contact: Mark Rauscher(6803)
ATTACHMENTS
COVID-19 Community Prevalence Study Full Proposal 2020 0610.pdf
COVID-19 Community Prevalence Study Timeline 2020 0609.pdf
apps.cfwnet.org/council_packet/mc_review.asp?ID=28085&councildate=8/4/2020 2/2